- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Escape Bio hatches $73m
Escape Bio, a spinout of Gladstone Institutes, has secured the return of Osage University Partners, Novartis, Novo and Johnson & Johnson.
Sep 16, 2020MDLive goes to Sixth Street for $50m
The investment firm supplied $50m for telehealth platform developer MDLive, which already counts Sentara, Cigna, Sutter Health, Novo and HCSC as investors.
Sep 16, 2020Escient scratches $77.5m series B itch
The Johns Hopkins spinout has raised cash from OUP as it looks to move its first candidate, targeting skin itch complications, into the clinic.
Sep 16, 2020Courier picks up series A funds
The notification software startup received backing from strategic investors Twilio, Slack and SendGrid in a $10.1m round that will fund hiring and product development.
Sep 16, 2020Daily deal net: September 15, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 15, 2020Klarna clasps on to $650m
Bonnier has bought into the payment services provider at a $10.65bn valuation alongside a $650m primary round led by Silver Lake.
Sep 15, 2020Biocytogen brings in $142m
China Life has returned for a $142m series D-plus round for cancer treatment developer Biocytogen, having already co-led its $77m series D round 13 months ago.
Sep 15, 2020Symbiome simulates $15m
Mission Bay Capital has placed a bet on Symbiome, creators of a skin care range intended to emulate our ancestor’s microbiome.
Sep 15, 2020Cordovan dives out of QUB’s TruCorp
Cordovan Capital Partners has sold its stake in QUB-founded clinician training equipment supplier TruCorp at a 10.4-fold return.
Sep 15, 2020Outset Medical outpaces expectations in $242m IPO
Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.
Sep 15, 2020Syncona settles Resolution with $34.5m series A
Syncona has equipped Resolution with funding to explore a restorative liver therapy based on the research of Edinburgh's Prof Stuart Forbes.
Sep 15, 2020Neogene sends for $110m series A
Syncona, Jeito Capital and EcoR1 Capital have co-led the Netherlands Cancer Institute-founded Neogene Therapeutics' series A round.
Sep 15, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


